Lapacho (Tabebuia impetiginosa)

Lapacho (Tabebuia impetiginosa) is a South American tree bark containing beta-lapachone and other naphthoquinones that demonstrate antimicrobial and anticancer activity in laboratory studies. The primary bioactive compounds work by generating reactive oxygen species and interfering with cellular energy production.

Origin & History

Lapacho (Tabebuia impetiginosa), also known as Pau d'Arco, is a tree native to the rainforests of South America, particularly Brazil, Argentina, and Paraguay. The medicinal part is primarily the inner bark, extracted via decoction, infusion, or solvent methods, containing 2-7% lapachol and other quinone compounds.

Historical & Cultural Context

In South American traditional medicine, particularly among indigenous groups in Brazil and Argentina, lapacho inner bark has been used for centuries as a tea for infections, inflammation, wounds, and as a general tonic. Scientific interest began in the 19th century, with lapachol first isolated in 1882.

Health Benefits

• Antimicrobial activity demonstrated in vitro against parasites like T. cruzi (complete inhibition at 0.8-5.0 µg/mL beta-lapachone) - preliminary evidence only
• Potential anticancer properties shown in vitro against human tumor cell lines (MCF-7, NCI-H460, HeLa, HepG2) with GI50 values of 76-110 µg/mL - no human studies available
• Antimalarial effects observed in preclinical models with 74% oxygen uptake inhibition in Plasmodium at 100 mg/L - animal studies only
• Anti-inflammatory properties suggested by traditional use patterns - no clinical trials identified
• Wound healing applications in traditional medicine - evidence limited to historical use

How It Works

Beta-lapachone and other naphthoquinones in lapacho generate reactive oxygen species through redox cycling, causing oxidative stress in target cells. These compounds also interfere with mitochondrial function and DNA synthesis by inhibiting topoisomerase enzymes. The antimicrobial effects occur through disruption of parasite cellular respiration and membrane integrity.

Scientific Research

No human clinical trials, RCTs, or meta-analyses were identified in the available research. Evidence is limited to preclinical in vitro and animal studies, with methanol extracts showing cytotoxic effects on cancer cell lines and beta-lapachone demonstrating antiparasitic activity.

Clinical Summary

Current evidence is limited to in vitro laboratory studies with no published human clinical trials. Beta-lapachone showed complete inhibition of T. cruzi parasites at concentrations of 0.8-5.0 µg/mL in cell culture studies. Anticancer activity was demonstrated against human tumor cell lines (MCF-7, NCI-H460, HeLa, HepG2) with GI50 values ranging from 76-110 µg/mL. These preliminary findings require validation through animal studies and human clinical trials before therapeutic applications can be established.

Nutritional Profile

Lapacho (Tabebuia impetiginosa) is consumed primarily as a bark tea (pau d'arco) rather than a food, so it lacks a conventional macronutrient profile (negligible protein, fat, carbohydrates, and calories per serving). Its significance lies entirely in its bioactive phytochemical composition. **Key bioactive compounds:** • **Naphthoquinones** – the most pharmacologically relevant class: **beta-lapachone** (3,4-dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran-5,6-dione) typically present at ~2–3% of dry inner bark weight; **lapachol** (2-hydroxy-3-(3-methyl-2-butenyl)-1,4-naphthoquinone) at ~1–2% of dry bark; **dehydro-alpha-lapachone** in trace-to-minor amounts. • **Furanonaphthoquinones** – including alpha-lapachone and related derivatives at lower concentrations (~0.1–0.5% dry weight). • **Iridoids** – including catalposide and related compounds contributing to anti-inflammatory activity. • **Benzoic acid derivatives** – such as vanillic acid, p-hydroxybenzoic acid. • **Flavonoids** – quercetin and kaempferol glycosides detected in minor quantities (~0.05–0.3% dry weight). • **Cyclopentene dialdehydes** – trace amounts identified in bark extracts. • **Minerals (per typical bark infusion, ~10 g bark/L):** calcium (~15–30 mg/L), iron (~1–3 mg/L), magnesium (~5–12 mg/L), potassium (~20–50 mg/L), manganese (~0.5–2 mg/L), zinc (trace), selenium (trace). These values are approximate as bark mineral content varies significantly with soil conditions and harvest location. • **Fiber:** Bark material is high in insoluble fiber (cellulose, lignin ~40–55% dry weight), but this is typically discarded after brewing; negligible fiber enters the tea infusion. **Bioavailability notes:** Beta-lapachone has limited oral bioavailability (~20–25% in animal models) due to poor aqueous solubility (~0.038 mg/mL at pH 7.4) and rapid hepatic metabolism via NQO1 (NAD(P)H:quinone oxidoreductase 1)-dependent pathways. Lapachol shows somewhat better absorption but undergoes significant first-pass metabolism. Hot water extraction (traditional decoction method, simmered 15–20 minutes) extracts approximately 10–30% of total naphthoquinones from bark. Concurrent intake with dietary fats may modestly improve absorption of lipophilic naphthoquinones. The mineral content in tea infusions has generally low bioavailability due to potential chelation by tannins present in the bark.

Preparation & Dosage

No clinically studied dosage ranges in humans are available. Preclinical studies used concentrations of 100 mg/L for antimalarial effects or 0.8-5.0 µg/mL beta-lapachone for antiparasitic activity. Traditional preparation involves bark decoction as tea. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Green tea extract, Vitamin C, Turmeric, Cat's claw, Resveratrol

Safety & Interactions

Lapacho may cause gastrointestinal upset, nausea, and dizziness at high doses based on traditional use reports. The naphthoquinone compounds could potentially interact with anticoagulant medications due to vitamin K antagonism. Safety during pregnancy and breastfeeding has not been established through clinical studies. Individuals with bleeding disorders or those taking blood-thinning medications should consult healthcare providers before use.